stockrowZai Lab Limited Unsponsored ADR
ZLAB Healthcare Biotechnology
Zai Lab Limited Unsponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $460.2 million, up 15.3% from fiscal 2024.
- Revenue
- −6.79%
- EPS
- −24.3%
- Free cash flow
- −95.5%
- Total debt
- +24.3%
Quarter to September 2026, against a year earlier
Follow ZLAB
Alert me
Zai Lab Limited Unsponsored ADR (ZLAB) Operating margin
Zai Lab Limited Unsponsored ADR's operating margin over the twelve months to 30 September 2026 was −63.0%, down 13.1 percentage points from fiscal 2025 (−49.9%). Over the past ten years it has ranged from −109,897.7% (fiscal 2018) to 0.00% (fiscal 2017); the current reading is higher than 73% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −49.9% | 20.85 |
| FY2024 | −70.7% | 66.73 |
| FY2023 | −137.4% | 50.60 |
| FY2022 | −188.0% | 297.06 |
| FY2021 | −485.1% | 131.35 |
| FY2020 | −616.5% | 948.40 |
| FY2019 | −1,564.9% | 108,332.82 |
| FY2018 | −109,897.7% | (109,897.67) |
| FY2017 | 0.00% | 0.00 |
| FY2016 | 0.00% | 0.00 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −58.2% | 13.75 |
| Jun 2026 | −72.0% | (2.29) |
| Mar 2026 | −69.7% | (15.27) |
| Dec 2025 | −54.4% | (12.34) |
| 27 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ADMA ADMA Biologics Inc compare | 46.5% |
| MBX MBX Biosciences, Inc. compare | 0.00% |
| PHVS Pharvaris N.V. compare | 0.00% |
| ZLAB Zai Lab Limited Unsponsored ADR | −63.0% |
| XNCR Xencor, Inc. compare | −205.8% |
| RCUS Arcus Biosciences, Inc. compare | −475.0% |
| RXRX Recursion Pharmaceuticals, Inc. compare | −725.4% |
| NAMS NewAmsterdam Pharma Company N.V. compare | −900.1% |
| CLDX Celldex Therapeutics, Inc. compare | −36,733.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on ZLAB
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement